Experimental group | Wound area (cm2) and percentage of wound contraction | |||||
---|---|---|---|---|---|---|
Day 0 | Day 5 | Day 10 | Day 15 | Day 21 | % wound contraction | |
Gp-I (Normal control) | – | – | – | – | – | – |
Gp-II (Negative control) | 3.37 ± 0.45 | 3.19 ± 0.45 | 2.83 ± 0.44 | 1.42 ± 0.55 | 0.33 ± 0.09 | 90.23% |
Gp-III (Plain Gel control) | 3.2 ± 0.29 | 2.7 ± 0.48 | 2.05 ± 0.30 | 0.79 ± 0.39 | 0.41 ± 0.15 | 87.18% |
Gp-IV (Marketed Gel) | 3.37 ± 0.28 | 3.5 ± 0.25 | 2.66 ± 0.27 | 0.95 ± 0.37 | 0.19 ± 0.08 | 94.72% |
Gp-V (Formulated 200 mg gel) | 3.25 ± 0.27 | 2.91 ± 0.27 | 1.64 ± 0.34 | 0.50 ± 0.29 | 0.14 ± 0.06 | 95.69% |